Palo Alto Investors »

Xenon Pharmaceuticals shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.0M 51k 58.15
2025-12-31 $4.3M 97k 44.82

More positions owned by Palo Alto Investors

Insmed Com Par $.01 (INSM)
ACADIA Pharmaceuticals (ACAD)
Ptc Therapeutics I (PTCT)
BioMarin Pharmaceutical (BMRN)
United Therapeutics Corporation (UTHR)
Anaptysbio Inc Common (ANAB)
Mirum Pharmaceuticals (MIRM)
Dyne Therapeutics (DYN)
Biogen Idec (BIIB)
Disc Medicine (IRON)
Iovance Biotherapeutics (IOVA)
Syndax Pharmaceuticals (SNDX)
Annexon (ANNX)
Amicus Therapeutics (FOLD)
Novocure Ord Shs (NVCR)

View all positions for Palo Alto Investors

Top funds holding Xenon Pharmaceuticals

FMR
venBio Select Advisor
BlackRock
Wellington Management Company
Driehaus Capital Management
Polar Capital Holdings
Henderson Group
Citadel Advisors
Capital Research and Management Company - Division 3
State Street Corporation
Susquehanna International
Affinity Asset Advisors
Deerfield Management Company
Holocene Advisors
Alliancebernstein

View all funds holding Xenon Pharmaceuticals